Which closed-end funds own Jazz Pharmaceuticals PLC?
5 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $18.4M. Security type: common equity. Country: Ireland. CUSIP G50871105 · ISIN IE00B4Q5ZN47 · ticker JAZZ.
Holdings are historical filings (report dates Jun 30, 2026 – Jul 31, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| HQH abrdn Healthcare Investors | Healthcare | 0.82% | $11.2M | 46,565 sh | $1.4B | 7.5% discount | Jun 30, 2026 |
| HQL abrdn Life Sciences Investors | Healthcare | 0.54% | $3.7M | 15,453 sh | $690M | 3.5% discount | Jun 30, 2026 |
| THW abrdn World Healthcare Fund | Healthcare | 0.41% | $2.9M | 11,844 sh | $689M | 4.3% discount | Jun 30, 2026 |
| SPXX Nuveen S&P 500 Dynamic Overwrite Fund | Covered Call / Option Income | 0.02% | $610K | 2,533 sh | $2.9B | NAV unavailable | Jun 30, 2026 |
| BRW Saba Capital Income & Opportunities Fund | U.S. Equity | -0.01% | $-35.1K | -139 sh | $351M | 17.8% discount | Jul 31, 2026 |
5 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Also listed in filings as: Jazz Pharmaceuticals Plc.
Related securities from the same issuer
| Security | Type | Funds holding |
|---|---|---|
| Jazz Pharmaceuticals PLC | loan | 2 |
| Jazz Pharmaceuticals PLC | common equity | 2 |
Issuer-level search for “JAZZ” → · Compare two funds’ portfolios →